de Boisriou, Isaure https://orcid.org/0009-0007-8406-3250
Ellouze, Sami https://orcid.org/0000-0003-2268-7539
Kassasseya, Christian https://orcid.org/0000-0003-2045-4985
Feral-Pierssens, Anne-Laure
Gerlier, Camille https://orcid.org/0000-0003-1991-4083
Chauvin, Anthony https://orcid.org/0000-0001-8819-0061
Beaune, Sebastien https://orcid.org/0000-0001-9299-6703
Dubreucq, Evelyne https://orcid.org/0009-0001-7412-8619
Pereira, Laurent
Chocron, Richard https://orcid.org/0000-0002-5498-8937
Khellaf, Mehdi https://orcid.org/0000-0001-5009-4744
Mariotte, Éric https://orcid.org/0000-0002-3614-0457
Zafrani, Lara https://orcid.org/0000-0002-7805-3116
Peyrony, Olivier https://orcid.org/0000-0001-6831-0054
Article History
Received: 28 July 2023
Accepted: 8 October 2023
First Online: 1 November 2023
Declarations
:
: OP has received honoraria for talks on behalf of BMS and Qiagen, and expertise for Sanofi. EM has received lecture fees from Sanofi and Takeda. LZ reports receiving fees for lectures for MSD and Sanofi and her institution received a research grant from Jazz Pharmaceuticals.
: Not applicable.
: The collection and use of data was approved by the institutional review board (CIC Clermont-Ferrand — IRB no. 5891; Ref: 2007–16).